Not a Client?
Find Out More!

America is re-opening and it is not ready. Accurate and speedy tests are potentially the only sustainable way to safely reopen economies around the world. However, major challenges remain for both COVID-19 diagnostic and antibody testing.

In WILTWs March 26, 2020, April 2, 2020 and April 9, 2020, we made the case that rapid-health screening and testing is a new multi-billion-dollar industry in the making, and that ramping up diagnostic and antibody testing was essential to reopening global economies. Reopening economies in the absence of proper testing and tracing infrastructure could be catastrophic. Second waves are already being seen in countries like Singapore, a nation whose government was the first in the world to back an automated tracing service, the TraceTogether app, but has seen only 10% to 20% compliance. President Trump noted this week that he is considering “phase-II” of the U.S. coronavirus response plan, including reopening the economy even if it leads ...

Want to read more?

SUBSCRIBE TODAY

Already a subscriber? Login here.

SUBSCRIBE NOW!

OR SIGN-UP FOR A COMPLIMENTARY TRIAL

GET STARTED!

A 38-year track record is no guarantee of success, but can you afford to bet against it?

Become a 13D client today or learn more about our research.

Get Started!